This inventor holds 1 USPTO granted patent. Top assignee: Galecto Biotech Ab. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Peter Timmins: Patent Activity in Pharmaceutical Innovation.
Introduction
Peter Timmins is an inventor associated with Cheshire, Great Britain. His patent activity includes work on a stabilized amorphous form of a pharmaceutical compound and its potential use in oral treatments.
Latest Patents
The supplied information lists one patent for Peter Timmins: “Amorphous form of 5-Bromopyridin-3-yl 3-deoxy-3-[4-(3,4,5-trifluorophenyl)-1H-1,2,3-triazol-1-yl]-1-thio-alpha-d-galactopyranoside.” The patent describes a stabilized amorphous form of the compound, oral compositions containing a therapeutically effective amount, and methods of treating diseases or disorders by administering such a composition to a person in need of treatment. The listed patent count is 1 patent.
Career Highlights
Timmins is associated with Galecto Biotech AB, a biotechnology company. The patent described here reflects work involving pharmaceutical formulation and potential therapeutic applications.
Collaborations
Lise Gravelle is identified as a coworker of Timmins. The supplied information does not specify their particular roles or contributions to the patent.
Conclusion
Peter Timmins’s listed patent concerns a stabilized amorphous pharmaceutical compound, oral formulations, and potential treatment methods, highlighting his connection to pharmaceutical innovation at Galecto Biotech AB.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile